
|Articles|July 1, 2007
- Volume 0 0
Update on Investigational Alzheimer's Drug
Author(s)Susan Farley
Advertisement
Voyager Pharmaceutical Corp recently informed its shareholders of preliminary results from a trial of an investigational drug to treat Alzheimer's disease (AD). The researchers studying the drug, Memryte, observed positive effects among women but not among men.
The findings have prompted Voyager to focus on developing the drug to treat AD specifically for women.
Articles in this issue
about 19 years ago
pharmacy TECHNOLOGY newsabout 19 years ago
pharmacy TECHNOLOGY productsabout 19 years ago
health-systems PRODUCT newsabout 19 years ago
generic times product newsabout 19 years ago
can you READ these Rxs?about 19 years ago
A closer look at new FDA actionsabout 19 years ago
can you READ these Rxs?about 19 years ago
compounding HOTLINEabout 19 years ago
Is There Science in Quality?about 19 years ago
Vaccines: Are You Protected?Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
New CKD Outcome Set Tells Pharmacists What to Measure
2
FDA Approves Zilganersen Injection, First Drug for Alexander Disease
3
AAP Issues 2026-2027 Guidance on RSV and COVID-19 Immunization
4
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
5


































































































